Zoltan Vajo

Summary

Publications

  1. pmc A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial
    Zoltan Vajo
    University of Debrecen, Medical and Health Sciences Center, Debrecen, Hungary
    Clin Vaccine Immunol 19:313-8. 2012
  2. doi request reprint Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children
    Zoltan Vajo
    National Center for Immunology and Allergy, State Health Center, Martonhegyi ut 6, Budapest, Hungary
    Pediatr Infect Dis J 27:1052-6. 2008
  3. doi request reprint Influenza A (H5N1) pandemic prototype vaccine Fluval
    Zoltan Vajo
    University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
    Expert Rev Vaccines 8:619-24. 2009
  4. doi request reprint The seasonal influenza vaccine Agriflu(®)
    Zoltan Vajo
    University of Debrecen, Medical and Health Sciences Center, Debrecen, Hungary
    Expert Rev Vaccines 10:1513-7. 2011
  5. doi request reprint Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial
    Zoltan Vajo
    University of Debrecen, Medical and Health Sciences Centre, Debrecen, Hungary
    Lancet 375:49-55. 2010
  6. pmc A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development
    Zoltan Vajo
    University of Debrecen, Debrecen, Hungary
    J Virol 84:1237-42. 2010
  7. doi request reprint Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?
    Zoltan Vajo
    National Center for Allergy and Immunology, Budapest, Hungary
    Influenza Other Respir Viruses 2:221-8. 2008
  8. pmc Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to
    Gyorgy Fazekas
    Omninvest Ltd, Pilisborosjeno, Budapest, Hungary
    Clin Vaccine Immunol 16:437-43. 2009
  9. pmc Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination
    Julia Sarkadi
    Division of Virology, National Center for Epidemiology, Budapest, 1097, Hungary
    Arch Virol 158:2577-81. 2013
  10. doi request reprint Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study
    Zoltan Vajo
    University of Debrecen Medical Center, Debrecen, Hungary
    Wien Klin Wochenschr 121:202-8. 2009

Collaborators

  • Zoltan Kis
  • Gyorgy L Nadasy
  • Albert Csaszar
  • I Tarjan
  • Gyorgy Paragh
  • Julia Sarkadi
  • Istvan Jankovics
  • Gyorgy Fazekas
  • Dora Scheiber
  • Szabolcs Varbiro
  • Ildikó Visontai
  • Kinga Fodor
  • Mate Jankovics
  • Eva Gonczol
  • József Skáre
  • Rita Martosne-Mendi
  • Istvan Szilvasy
  • Zoltan Urban
  • Gergely Balaton
  • Katalin Nagy
  • Gyorgy Fekete
  • Lajos Kosa
  • Nandor Acs
  • Bela Szekacs
  • Emil Monos
  • James V Felicetta
  • Miklós Lóránt

Detail Information

Publications12

  1. pmc A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial
    Zoltan Vajo
    University of Debrecen, Medical and Health Sciences Center, Debrecen, Hungary
    Clin Vaccine Immunol 19:313-8. 2012
    ..All adverse events were rare, mild, and transient. We found that the present reduced-dose vaccine is safe and immunogenic in healthy adult and elderly subjects and triggers immune responses that comply with licensing criteria...
  2. doi request reprint Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children
    Zoltan Vajo
    National Center for Immunology and Allergy, State Health Center, Martonhegyi ut 6, Budapest, Hungary
    Pediatr Infect Dis J 27:1052-6. 2008
    ..Children may be particularly vulnerable to the pandemic virus, and they may react differently than adults to vaccines. We report the results of the first clinical trial of an H5N1 vaccine in children...
  3. doi request reprint Influenza A (H5N1) pandemic prototype vaccine Fluval
    Zoltan Vajo
    University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
    Expert Rev Vaccines 8:619-24. 2009
    ....
  4. doi request reprint The seasonal influenza vaccine Agriflu(®)
    Zoltan Vajo
    University of Debrecen, Medical and Health Sciences Center, Debrecen, Hungary
    Expert Rev Vaccines 10:1513-7. 2011
    ....
  5. doi request reprint Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial
    Zoltan Vajo
    University of Debrecen, Medical and Health Sciences Centre, Debrecen, Hungary
    Lancet 375:49-55. 2010
    ..We investigated the safety and immunogenicity of a whole-virion, inactivated, adjuvanted pandemic H1N1 vaccine in adult and elderly volunteers, given without or simultaneously with the 2009-10 seasonal trivalent influenza vaccine...
  6. pmc A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development
    Zoltan Vajo
    University of Debrecen, Debrecen, Hungary
    J Virol 84:1237-42. 2010
    ....
  7. doi request reprint Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?
    Zoltan Vajo
    National Center for Allergy and Immunology, Budapest, Hungary
    Influenza Other Respir Viruses 2:221-8. 2008
    ..Here we report the results of the yearly licensing studies of the past 11 influenza seasons (1997-2007) with a trivalent, inactivated whole virus vaccine with an aluminum phosphate adjuvant system...
  8. pmc Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to
    Gyorgy Fazekas
    Omninvest Ltd, Pilisborosjeno, Budapest, Hungary
    Clin Vaccine Immunol 16:437-43. 2009
    ..Our findings highlight the importance of stockpiling, since cross-immune reactions induced by prepandemic vaccines will likely reduce morbidity and mortality in case of a pandemic...
  9. pmc Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination
    Julia Sarkadi
    Division of Virology, National Center for Epidemiology, Budapest, 1097, Hungary
    Arch Virol 158:2577-81. 2013
    ..Our results demonstrate the protective efficacy of the NIBRG-14 strain against the challenge virus and the usefulness of these small birds in protection studies of influenza vaccines. ..
  10. doi request reprint Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study
    Zoltan Vajo
    University of Debrecen Medical Center, Debrecen, Hungary
    Wien Klin Wochenschr 121:202-8. 2009
    ....
  11. ncbi request reprint Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy
    Szabolcs Varbiro
    Second Department of Obstetrics and Gynecology, Semmelweis University, Faculty of Medicine, Budapest, Hungary
    Menopause 9:122-6. 2002
    ....
  12. ncbi request reprint Echocardiographic findings in patients with Williams-Beuren syndrome
    Dora Scheiber
    Semmelweis Medical School, Budapest, Hungary
    Wien Klin Wochenschr 118:538-42. 2006
    ....